In July 2019, the FDA announced a recall of textured Biocell implants made by Allergan. There is some connection between these devices and anaplastic large-cell lymphoma – a rare form of cancer.
Lymphoma cases due to implants are extremely low. Of the 40 million women with implants, only 300 to 500 have received a diagnosis of BIA-ALCL. Still, the news has brought implant removal to the forefront of public awareness. This potential health issue does not apply to implants other than the Biocell textured ones subject to the recall.